Skip to main content
Clinical Trials/IRCT20151123025202N16
IRCT20151123025202N16
Recruiting
Phase 3

Comparing the efficacy of local corticosteroid injection and Extracorporeal shockwave therapy in patients diagnosed with pes anserine bursitis

Hamedan University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Pes anserine bursitis.
Sponsor
Hamedan University of Medical Sciences
Enrollment
60
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of PAB according to clinical and paraclinical criteria by a specialist physician
  • Diagnosis period at least 3 months
  • Age 65\-18 years
  • Pain severity greater than 3 according to VAS scale

Exclusion Criteria

  • Comorbidity of other knee diseases such as advanced osteoarthritis, infection and ...
  • History of recent knee surgery or trauma
  • Vascular disease
  • History of corticosteroid therapy during the last 4 months

Outcomes

Primary Outcomes

Not specified

Similar Trials